Abstract
Background and purpose
The splenium of the corpus callosum is the most posterior part of the corpus callosum. Its embryological development, anatomy, vascularization, function, imaging of pathology, possible pathophysiological mechanisms by which pathology may develop and the clinical consequences are discussed.
Methods
A literature-based description is provided on development, anatomy and function. MR and CT images are used to demonstrate pathology. The majority of pathology, known to affect the splenium, and the clinical effects are described in three subsections: (A) limited to the splenium, with elaboration on pathophysiology of reversible splenial lesions, (B) pathology in the cerebral white matter extending into or deriving from the splenium, with special emphasis on tumors, and (C) splenial involvement in generalized conditions affecting the entire brain, with a hypothesis for pathophysiological mechanisms for the different diseases.
Results
The development of the splenium is preceded by the formation of the hippocampal commissure. It is bordered by the falx and the tentorium and is perfused by the anterior and posterior circulation. It contains different caliber axonal fibers and the most compact area of callosal glial cells. These findings may explain the affinity of specific forms of pathology for this region. The fibers interconnect the temporal and occipital regions of both hemispheres reciprocally and are important in language, visuospatial information transfer and behavior. Acquired pathology may lead to changes in consciousness.
Conclusion
The development, location, fiber composition and vascularization of the splenium make it vulnerable to specific pathological processes. It appears to play an important role in consciousness.
Keywords: Splenium, Corpus callosum, MRI, Anatomy, Pathophysiology, Consciousness
Introduction
The splenium is the most posterior and bulbous shaped part of the corpus callosum (CC). Anterior to the splenium, the remainder of the CC consists, respectively, of the narrow isthmus, the thicker corpus, the voluminous genu, with the thinnest part, called the rostrum, extending inferiorly to the anterior commissure.
The CC forms the bridge between the cerebral hemispheres, containing crossing axonal fibers from both hemispheres.
The fibers in the splenium are projections from the occipital-parietal and temporal cortex [1].
During the embryological phase, the development of the hippocampi and hippocampal commissure (HC) precedes the development of the CC. After developmental completion, the splenium has an intimate connection anteriorly with the HC [1].
The exact function of the splenium is not completely understood, but a splenial lesion may result in the disconnection of the cerebral hemispheres, with disruption of higher cortical function, loss of conscious processes and delirious behavior [2].
This article focuses on the embryological development of the CC, and the splenium in particular, together with that of the closely related HC. Furthermore, its normal anatomy, function and its vascularization are discussed.
The last section provides an overview of the majority of congenital and acquired splenial pathology, as seen on MRI and CT. We have categorized this section into three subsections to facilitate reading. The first subsection discusses pathology restricted to the splenium, with elaboration on pathophysiology of reversible splenial lesion syndrome (RESLES). The second subsection focuses on CNS diseases affecting the posterior parietal-occipital-temporal white matter, including metabolic disease, tumors and inflammatory disease, which may extend into or derive from the splenium, with special emphasis on tumors. The third subsection discusses generalized disorders, such as trauma, infarction and intracranial hypotension syndrome, which may specifically involve the splenium.
Embryological development of the CC and hippocampus and their postnatal anatomy
The development of the CC has long been believed to take place in a fixed order, starting with the genu during the 12th gestational week, followed by the isthmus, the splenium, and finally the rostrum during the 18–20th week of gestation [3, 4]. In 2010, Raybaud, however, hypothesized that the formation of the CC is based on fusion of separate segments. Anteriorly, containing the axons from the anterior hemisphere, and those from the posterior neocortex forming the splenium. This fusion hypothesis makes certain subtypes of CC agenesis, associated with other developmental brain disorders easier to understand [1].
There is a clear developmental relation of the CC with the hippocampus and hippocampal commissure. At week 7, a primary joining plate between the hemispheres, referred to as the lamina reuniens, starts to thicken. In the anterior part, fibers of the anterior commissure (AC) start to cross. In the dorsal part, the massa commisuralis is formed and becomes the bed for the ingrowth of commissural fibers of the CC [1, 4]. From 10 weeks, hippocampal-septal fibers develop, forming the early fornix. At 11 weeks, some of the fornix fibers cross the midline in the dorsal part of the lamina reuniens and form the HC [1, 4]. At 11–12 weeks, pioneer fibers of the prospective CC begin to penetrate the massa commisuralis in the primordium hippocampi, and at 12–13 weeks, an increasing number of fibers form the definitive commissural plate [4]. At 13 weeks, cingulate fibers and other neocortical fibers start forming the anterior CC and other neocortical fibers cross via the AC and HC. At 13–14 weeks, the anterior CC and splenium start to fuse, forming the entire CC [1].
Growth of the CC is associated with reduction of the hippocampal formation in the frontal lobe [5]. Kier et al. found that at 13 weeks, a large part of the medial surface of the cerebral hemisphere is occupied by the hippocampal formation, which runs along a wide hippocampal sulcus or fissure, extending from the olfactory tract, located in the frontobasal area, to the temporal lobe, forming the inner limbic arch [5].
At 14 weeks, during the development of the CC, the supracallosal hippocampus starts to regress, with the induseum griseum, also known as the supracallosal gyrus, overlying the CC, remaining as a remnant. The sulcus of the CC is a remnant of the embryological hippocampal sulcus and is located between the cingulate gyrus and the supracallosal gyrus. At 16 weeks, the cingulate gyrus and the temporal parahippocampal gyrus can be identified. Together with the subcallosal area, they form the outer limbic arch.
The CC grows more rapidly than the HC, and eventually, the splenium overrides the HC [4], which has become a triangular structure between the fornices, with a midline attachment to the undersurface of the splenium [1], as demonstrated in Fig. 1. In humans, the HC is usually very thin; however, in some cases, an enlarged HC may be mistaken for the splenium on a sagittal view [6].
The fibers of the HC and the splenial fibers, connecting the posterior parietal, the inferior temporal and occipital cortices of the two hemispheres, cross the midline together [1, 7]. A schematic drawing of the HC is provided by Ranson and Clark [5, 8]. Because of their intimate relationship and development, splenial agenesis may be associated with an agenesis or possibly an anterior shift in location of the HC, explaining the bilateral malrotation of hippocampi often seen in these cases [9].
After birth, the growth rate of the splenium exceeds that of the genu. At 8 months of age, the midsagittal splenium area achieves 55% of the average adult size [10].
Most splenial fibers are thought to be reciprocal and connect the hemispheres homotopically. De Lacoste et al. showed that callosal connections from the temporo-parietal-occipital junctional region course through the splenium and the caudal part of the body of the CC [11]. Neuroanatomical tracer studies have shown that together with the genu, the anterior and mid splenium contain the largest density of thin (> 0.4 μm) axonal fibers, connecting higher order processing areas of the parietal and medial temporal lobes. Thicker fibers (> 3–5 μm) are present in the posterior splenium, fusing the hemirepresentation of the visual field [12].
Between the age of 7 and 11 years, the splenium remains comparatively stable. In the age group of 11–15 years, relatively more rapid splenial growth occurs compared with the anterior CC [13]. The increase may be related to increased oligodendroglial proliferation associated with the larger diameter fibers, rather than increased axonal density [12]. A DTI study in adolescents and young adults has shown that in the splenium, until 18 years, age correlates with increased white matter integrity and therefore myelination, leading to increased fractional anisotropy [14]. During puberty, splenial size increase could facilitate maturing of multiple higher functions, such as reading and calculation skill, requiring visuospatial information transfer, allowing these functions to expand [15–17].
Arterial vascularization and venous drainage
The arterial vascularization of the splenium, based on examination of 30 adult human brains, is well illustrated by Kahilogullari et al. [18]. The splenium receives its blood supply from three arteries: the anterior pericallosal artery, which is a terminal branch of the anterior cerebral artery. The posterior pericallosal artery (branch of the posterior cerebral artery), also known as the splenial artery. Lastly, from the posterior accessory pericallosal artery. These arteries ramify into perforating branches, and the branches of both arteries anastomose to form a pericallosal pial plexus [18, 19]. Inside the CC, these arteries distribute numerous terminal or collateral branches, which run between the nervous fibers. They anastomose with homologous neighboring branches to form a vascular network, which is closely connected with the commissural fibers [20].
A detailed description of the venous drainage of the CC is provided by Wolfram-Gabel and Maillot [21]. They illustrate two drainage systems in a schematic drawing. The main system consists of callosal veins and venules and of callosocingulate veins. The splenium usually contains short callosal veins, which run downwards perpendicular to the central surface of the CC. The callosocingulate veins emerge from the peripheral surface to form long callosal veins, which drain the CC and cingulate gyrus. These veins join together at the central surface of the CC, to form the subependymal veins. Those in the posterior third of the CC drain into the septal veins and medial atrial vein, and eventually into the internal cerebral veins. Wolfram-Gabel and Maillot also describe an accessory drainage system, comprising the posterior pericallosal veins and the splenial veins, draining into the anterior straight sinus, into the vein of Galen, the basal vein, medial atrial vein or into the medial occipital vein.
Function
Transferring eloquent information between both hemispheres
Up to 1940, the neurological function of the CC was not understood. Callosotomy, used in the treatment of epilepsy, first reported in 1940, has allowed a better understanding of its function. It has led to the view that the CC is involved in transferring information between the cerebral hemispheres [15]. The splenium has been shown to be involved in visuospatial information transfer, language, reading and calculation scores, IQ, behavior and consciousness [15–17]. Fractionated anisotropy, the measure of axonal directionality, has been shown to have a positive correlation with processing speed, expressive vocabulary and single-word reading. Several studies have found splenial enlargement in dyslexia and reduction in attention-deficit hyperactivity disorder [22].
Disconnection syndrome
A known major side effect of a callosotomy, transecting the entire CC, is the so-called split brain or disconnection syndrome. The disconnection syndrome is a combination of disorders in cortical function such as alien limb syndrome, apraxia, tactile and/or visual anomia, agraphia neglect and dyslexia, and it is often of a transient nature [23]. Section of the splenium leads to a sensory disconnection syndrome, which expresses itself with neglect of visual stimuli presented only to the right or left visual field, if the verbal access to this information is interrupted. This has been proposed to result from isolating the dominant language hemisphere from visual information received by the non-dominant hemisphere [24], which can be explained by the primary visual and temporo-occipital and parietal association commissural fibers found in the splenium. Using fMRI and DTI, Fabri et al. found foci evoked by auditory and visual stimuli in the isthmus/splenium continuum and in the splenium itself. They suggest that proximal body representation is provided by callosal fibers running through the posterior isthmus and anterior splenium, transferring combined occipital located visual notion and parietal localized spatial representation [25]. These microanatomical and functional findings may explain why splenial lesions may be associated with confusion and most commonly altered mental status, with more specific findings of splenial compromise being hallucinations, psychosis and mutism [26].
Consciousness
With splenial lesions, the HC may also be affected, considering its close relation with the splenium. The exact function of the HC is not clarified. However, it might serve as a memory sluice, permitting information initially processed in the temporal lobe cortex of one hemisphere to be further processed partially in the contralateral hippocampus or to share specific memories which are predominantly dependent on one temporal lobe [27]. Damage to the hippocampal commissure, combined with the loss of visuospatial and auditory information transfer in splenial pathology and further disintegration of the cerebral network, may lead to changes in consciousness.
Using DTI, Zhang et al. determined that consciousness levels correlated strongly with a reduction of fractional anisotropy value in the corpus of the CC and moderately in the splenium, corresponding with increased demyelination [28]. Acute severing of the crossing fibers following head trauma has been shown to lead to altered mental status and even coma [29]. Furthermore, posttraumatic lesions in the splenium, combined with those in the dorsal brainstem, have been shown to be highly significant in predicting non-recovery in patients with a posttraumatic vegetative state [30].
Pathology affecting the splenium
Several articles have provided a pictorial overview of pathology affecting the entire CC [31–33]. However, few have been published on pathology solely affecting the splenium. In this article, pathology in the splenium is separated in three subsections: (A) acquired pathology primarily affecting the splenium, (B) acquired parietal-occipital-temporal cerebral pathology extending into or from the splenium and (C) congenital and acquired pathology involving the splenium in a general disorder.
A. Acquired pathology primarily affecting the splenium
A1.Reversible splenial lesions
Transient, reversible lesions in the splenium have been described in a wide range of disorders, including viral, bacterial and parasitic infections, treatment of infection with metronidazole, anti-epileptic drug (AED) toxicity or withdrawal, treatment with 5 fluorouracyl, hypoglycemia, hyponatremia and high altitude cerebral edema [31, 32, 34–36]. Similar lesions have been described on MRI in patients with Wernicke syndrome, with persisting cognitive impairment following thiamine replacement. It is, however, not known whether these splenial lesions were reversible, as no follow-up imaging was published [37, 38]. Furthermore, a case has been published with intravenous immunoglobulin therapy related reversible diffusion restriction in the entire splenium, extending into the parietal white matter [39].
The clinical-radiological condition associated with these lesions has been termed ‘reversible splenial lesion syndrome’ (RESLES) [34], ‘mild encephalitis/encephalopathy with a reversible splenial lesion’ (MERS) [40], ‘boomerang lesion’ [41] and recently cytotoxic lesions of the CC that show restricted diffusion (CLOCCs) [42]. We prefer the term RESLES, as the clinical presentation associated with the lesion is not always mild, as implied by the term MERS. CLOCCs does not necessarily imply reversibility and boomerang sign does not indicate the splenial location. In this section, we will use the term RESLES and MERS depending on the articles to which are referred.
MR imaging in RESLES
On MRI, during the acute phase of RESLES, localized signal intensity increase is seen on DWI with a reduced signal on the ADC map, consistent with cytotoxic edema [42–44]. The abnormal area is slightly hyperintense on T2 and FLAIR, and hypointense on T1, surrounded by normal crossing axons [31]. Contrast enhancement has only been published in one patient, treated prophylactically with AEDs. The authors suggested the enhancement to be due to more intense focal damage, confirmed by the presence of a residual lesion on follow-up [45]. This is also shown in Fig. 2d.
In adults, the reversible lesion is always located in the centre of the splenium, with an unsharp border and never extending laterally, and this has been referred to as MERS type 1 lesion [46, 47].
In children, lesions may also be small as demonstrated in Fig. 2a, which shows a lesion on DWI located in the center of the splenium in a girl with an entorovirus infection. Figure 2 b–d show MR images of a girl who was admitted with pneumoccocal meningitis with a larger splenial lesion on initial T2 and a small rightsided residual lesion on 5-year follow-up. Several articles have published more extensive lesions, extending into the entire CC and into the parietal white matter, and sometimes even into the frontoparietal white matter [42, 46, 48], also referred to as MERS type 2 lesions [46].
Timing of development and disappearance of RESLES lesions varies. In infections, lesions have been described to be visible from day 1 after presentation of clinical symptoms and disappearing within 1–2 weeks in most [34]. Following AED withdrawal, lesions have been found coincidentally between 24 h and 1 week. In patients who continued to use a AEDs, RESLES lesions have been shown up to 3 weeks after a last seizure [34].
Pathophysiological considerations
Several pathophysiological theories have been proposed for the development of transient splenial lesions.
One hypothesis focuses on the possibility that it may be related to arginine-vasopressin (AVP)/antidiuretic hormone (ADH) level. In 1956, Nyhan and Cooke already suggested that in CNS infections, hyponatremia may develop because of acute expansion of the extracellular fluid volume, which may follow increased production of ADH, limiting the capacity to excrete water in these patients [49]. In response to a brain injury such as infection or trauma, increased levels and enhanced effect of ADH may occur, referred to as syndrome of inappropriate secretion of ADH (SIADH) [50, 51].
In the kidney, ADH binds to receptors, which trigger an intracellular mechanism that opens AQP2 water channels allowing water to be reabsorbed from the urine into the cell. Opening of the AQP3 and AQP4 water channels at the basolateral cell membrane leads to reabsorption of intracellular water into the blood. This leads to hypervolemia, resulting in dilution and decrease in plasma osmolality, therefore hyponatremia. For a more detailed description, we refer to Verbalis et al. [52].
Sodium ions are the major cations of the extracellular fluid and potassium ions are the major cations of the intracellular fluid. To maintain internal fluid and electrolyte balance, water, sodium and potassium are in constant movement between both compartments, regulated by the sodium-potassium pump. The most important function of this pump is preventing cells from swelling. If sodium is not ‘pumped’ out, water accumulates within the cell, which causes swelling and ultimately bursting [53]. In the brain, this movement of water from the extracellular space into the cells in response to this osmotic gradient, results in cerebral edema.
It is a known fact that rapid correction of acute severe hyponatremia may lead to pontine myolinolysis [54]. With hyponatremia, the cells mostly involved in swelling are glial cells. Specific aquaporin water channels (AQP1 and AQP4) allow water to pass into the glial cells, whereas neurons are relatively spared from water entry [2, 51, 55]. Besides cytotoxic edema occuring at glial level, which has also been suggested by Prilipko et al [56], intramyelinic cytotoxic edema has also been proposed as a cause for a RESLES lesion [44, 57, 58].
The preference for a RESLES lesion to develop in the center of the splenium is unknown. Because of the bigger volume of the splenium compared to the remainder of the CC, the center contains the most compact area of callosal glia cells combined with a known largest density of thin (> 0.4 μm) axonal fibers in the anterior and mid splenium [12]. In case of insidious development of uncorrected hyponatremia, the larger density of AQP1 and AQP4 channels and a higher density of glutamate receptors [42] may make this area most vulnerable to water influx in glial cells and development of cytotoxic edema.
In 2009, Takanashi et al. showed that 25/30 patients with MERS had hyponatremia [59]. In 2015, the same group showed that five patients with MERS after mumps vaccination and mild encephalitis, all had hypotonic hyponatremia [55].
Although these findings underscore a relation between hyponatremia and RESLES lesions, a very limited number of cases have been described with hypernatremia [42]. Tsuji et al. described a case with influenza A infection scanned on day six, which had neither hypo- nor hypernatremia, presenting with an asymptomatic RESLES lesion with diffusion restriction [60].
Opposed to diffusion restriction seen in the acute stage of ischemia, which nearly always leads to irreversible damage if untreated, the reversibility of diffusion restriction and of behavioral symptoms, in a RESLES lesion has been explained by a transient inflammatory response following sustained hypo-osmolality. Inflammatory cytokines trigger a cascade, whereby massively increased amounts of glutamate enter the extracellular space and glutamate reuptake is blocked. The highly increased extracellular glutamate level leads to excitotoxic effect on certain receptors triggering the sodium-potassium pump, allowing sodium ions to enter cells and potassium ions to leave cells. This results in entering of water in glial cells and in neurons, resulting in cytotoxic edema and diffusion restriction [42, 51].
Pathology and RESLES
RESLES lesions have been described in infections, the use and withdrawal of antiepileptic drugs, in alcoholism and in hypoglycemia, all of which have been related to ADH and AVP. (Figure 2) In a literature review, Garcia-Monco et al. found 38 patients with RESLES with an encephalopathy in the setting of a systemic infection, without CSF parameters of infection and without seizures or AED treatment. Influenza A and B virus and human herpes virus are the most commonly found in the presence of RESLES [46, 61]. It has also been reported in a patient with Dengue fever [61], and in patients with mumps, adenovirus, rotavirus and streptococcal and E. coli bacteria [40]. In Fig. 3a, an MRI of a female patient with an entorovirus infection is presented. She was admitted on day 3 with several convulsions and fever. On day 4, she developed diminished consciousness, which she regained on day 7. In Fig. 3b–d, the MRI scan of a girl with pneumococcal meningitis is shown. She had limited contact with the outside world during the time of scanning. Clinically, 4 months after the meningitis, she had no cognitive deficits. Five years later, however, she developed behavioral changes, and on MRI, a small rightsided residual splenial lesion was seen.
In epileptic patients, AVP disbalance or enhancement of the antidiuretic effect, caused by chronic use of certain anti-epileptic drugs, such as phenytoin, carbamazepine and lamotrigine, may lead to hyponatremia and cerebral edema [34, 60, 62]. On the other hand, abrupt withdrawal of AEDs may cause a short period of disequilibrium, causing a syndrome of inappropriate antidiuresis. This could contribute to brain edema with splenial diffusion restriction representing cytotoxic edema [43, 51, 62], and perilesional increased signal on T2 and FLAIR, consistent with vasogenic edema [43, 53]. RESLES lesions do not seem to be caused by seizures, independent of type and frequency [34]. This is underscored by the finding that these lesions have also been described in three non-epileptic patients treated with AEDs [45].
In alcoholism, callosal abnormalities, particularly in the splenium and the genu, have been attributed to vitamin B deficiency [63]. However, in our opinion, severe alcohol consumption causes chronic dehydration and loss of electrolytes, such as sodium, which together with increases in ADH, results in hyponatremia.
Hypoglycemia may also be associated with RESLES lesions in neonates [64], and in adults [65]. AVP also appears to play a role in glucose homeostasis, insulin resistance and diabetes mellitus (DM). It is markedly elevated in patients with poorly controlled DM and therefore may result in hyponatremia [66]. Figure 4 illustrates an MRI of a 5-day-old neonate with reversible splenial diffusion restriction caused by hypoglycemia.
Clinical presentation of RESLES
The most common prodromal symptom of RESLES is fever. Patients with RESLES lesions may present without clinical symptoms, as was found in a large retrospective study by Kim et al. involving 1200 epileptic patients scanned with MRI. An asymptomatic lesion was found in six subjects, scanned 3–6 weeks following their last seizure [67]. RESLES lesions after AED withdrawal are also not always symptomatic [34].
Delirium is, however, the most commonly observed clinical symptom in over half of patients, followed by disturbed consciousness and seizures, recovering within a month [2, 40]. Seizure activity may be explained by loss of small organic osmolytes such as glutamate, which may result in transient neurological abnormalities [51]. Other clinical manifestations are confusion, disorientation, ataxia, disconnection syndrome, dysarthria, headache, coma and hallucinations [40, 68], most of which are also described in the presence of hyponatremia [50].
Of patients with influenza, > 10% has been shown to have delirious behavior. In their study of 370 patients with influenza, Takanashi et al. found MERS lesions in 5 of 11 patients (3%) experiencing intermittent episodes of delirious behavior [2, 40].
Katoh et al. found that 4/70 patients with hypoglycemia showing RESLES on DWI, clinically presented with a disturbed consciousness [65].
The correlation between a RESLES lesion and symptom relief is controversial [69]. Although most RESLES lesions disappear following clinical remission and have a favorable outcome, two cases have been described in which these lesions persisted 6–9 months, independent of clinical improvement [69]. A delay in treatment may, however, may lead to irreversible and prolonged consciousness disturbance [65].
To summarize, we propose that RESLES lesions could be considered to represent an osmotic imbalance syndrome. It may result from correction of, or in the presence of a more insidious chronic hyponatremia, due to imbalance of AVP. Combined with excitotoxic effect of Glutamate, water is enabled to enter into neuronal cells, as suggested by Starkey et al. [42]. Why some patients remain asymptomatic, while others present with severe neurological symptoms, and in some patients, RESLES lesions remain present after clinical recovery is unknown. Possibly, this may be related to the speed at which the hyponatremia developed and the timing of the scan.
A2. Ventral splenial edema
In adults, a rim of hyperintense signal on FLAIR at the ventral border of the splenium has been described in older patients and those that have been treated with radiotherapy [70]. This finding is illustrated in Fig. 5, showing FLAIR images of an older patient with mood and behavioral changes and cognitive decline.
Pekala et al. describe one autopsy case, which showed loss of axons and myelin sheaths and isomorphic gliosis. In their study, they found a clear correlation between this finding and white matter disease seen in normal aging [70].
We hypothesize that this region may represent edema in the hippocampal commissure. The pathological significance and the clinical relevance have not been studied so far and the precise effect on memory and behavior is unknown.
B. Acquired parietal-occipital-temporal cerebral pathology extending into or from the splenium
B1.Metabolic diseases
Metabolic diseases, such as Metachromatic Leukodystrophy and Mucopolysaccharisodoses, usually affect the entire CC [32]. In Leighs disease, sole involvement of the splenium and no extension into the remainder of the CC is exceptional and has been described in only two case reports [71, 72]. In the following section, we will focus on (a) Wilson’s disease, in which the splenium may be affected; (b) X-linked adrenoleukodystrophy (X-ALD), which initially affects the splenium; and (c) Krabbe’s disease, which involves the splenium at a later stage, together with the peritrigonal white matter.
B1a. Wilson’s disease
Wilson’s disease (WD), also known as hepatolenticular degeneration, is an autosomal recessive disease of impaired copper metabolism, caused by a mutation in the ATP7B gene, encoding copper-transporting ATPase in the liver [73].
On MRI, brain lesions are usually bilateral and symmetrical and involve the basal ganglia, thalami, mesencephalon, pons and dentate nucleus, as shown in Fig. 5. Abnormal T2 signal in the splenium is not unusual and found in nearly a quarter of the patients [73, 74]. Trocello et al. describe that on follow-up, the splenial lesion does not change, noting that this is an argument against transient change [74]. However, the MRI follow-up in our patient showed only a residual splenial abnormality on DWI as shown in Fig. 6.
Clinically, these patients may present with neurological, psychiatric, liver and renal symptoms and corneal Kayser-Fleischer rings [73]. Although Trocello et al. describe that no clinical signs of disconnection were observed, possibly due to the slowly progressive nature, Zhou et al. report that WD patients with splenial lesions have more severe neurological and psychiatric dysfunction [73, 74].Our patient, a 30-year-old man presented with longstanding progressive cerebellar ataxia, dysarthria, swallowing disturbance, gait difficulties, bradyphrenia, memory deficits and autonomic disturbance.
B1b. X-linked adrenoleukodystrophy
X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder caused by a mutation in the ABCD1 gene [75]. In this disorder, fatty acids build up in the body. The accumulated fatty acids are particularly harmful and can destroy specific cells and organs, including the myelin sheathes of the brain.
In 80% of homozygote X-ALD patients, the initial demyelinating lesion may precede symptoms. On MRI, it is localized in the splenium and progresses into the adjacent parieto-occipital white matter [75–77]. The abnormalities are hyperintense on T2-weighted images and FLAIR, as shown in Fig. 7. The abnormalities may show variable contrast enhancement [32].
Clinically, children with X-ALD, initially present with visual difficulties, behavioral problems, hyperactivity and emotional lability. Our patient presented with behavioral disturbances, loss of cognitive functions and since several months development of abnormal gait. In general these symptoms are rapidly progressive, especially in the juvenile form. It may lead to death within 2–4 years or to a vegetative state, which could be explained by splenial involvement of the patient [76].
B1c. Krabbe’s disease
Krabbe’s disease, or globoid cell leukodystrophy, is an autosomal recessive lysosomal storage disease affecting the central nervous system, with a primary defect in the galactosyl-cerebrosidase enzyme. This defect leads to impaired degradation of acetosylceramide, resulting in apoptosis of myelin forming cells [78].
Brain pathology is characterized by globoid cells, which have multiple nuclei derived from microglia [79].
In adult Krabbe disease, on MRI, the corticospinal tracts and white matter in the parietal lobes are affected, with frequent involvement of the splenium. These findings are also present in a boy of which the MRI scan is shown in Fig. 8. The splenial preference may possibly be related to the presence of microglia fountains (see section B on lymphoma) [80].
Clinically, Krabbe’s disease often presents during early childhood with irritability, psychomotor regression and at the end stage the child becomes decerebrate with loss of contact with surroundings [81], which may be related to splenial involvement. Our patient with proven Krabbe’s disease, based on two mutations in the GALC gene, presented with progressive gait disturbance and visual disorder month before MRI, followed by panic attacks 2 weeks after MRI. One and a half years later he developed loss of contact with his surroundings.
B2. Tumors
Glioblastoma multiforme (GBM) and lymphoma are known to develop in or extend into the splenium or the remainder of the CC [82]. We would also like to add the diffuse infiltrating glioma (previously known as gliomatosis cerebri) to this list. As oligodendrogliomas often develop in the frontal lobes, they usually involve the genu of the CC if they cross the midline and therefore we have not included this tumor in the discussion [33].
The reason why only aggressive tumors involve the CC is not known. It has been suggested that the compact nature of the white matter tracts in the CC may make this structure relatively resistant to infiltration by edema or tumor spread [83].
B2a. Glioblastoma multiforme and diffuse infiltrating glioma type tumor
Glioblastoma multiforme (GBM) is the most aggressive diffuse astrocytic tumor (WHO grade IV). Its most common imaging appearance is that of a large heterogeneous mass in the supratentorial white matter, which may involve the splenium through direct extension along the white matter tracts [84, 85].
Diffuse glioma type tumor, formerly known as gliomatosis cerebri [86, 87], is a rare, diffusely growing malignant neuroepithelial tumor characterized by extensive brain infiltration, involving more than two cerebral lobes [88]. On T2-weighted images, diffuse gliomatous tumor infiltration in the splenium is less hyperintense than peritumoral vasogenic edema. Although splenial involvement is not specifically described in articles on gliomatosis, cases have been demonstrated in multiple article figures.
In a study by Peretti-Viton et al., the CC was involved in 8 of 9 patients with gliomatosis cerebri, with splenial involvement shown in one figure [88]. Desclée et al. describe 1 of 12 patients to have extension into the splenium [89]. Kontzialis et al. show a child with diffuse glioma in the splenium [32]. In Fig. 9, an MRI scan of a male patient with a biopsy proven GBM is shown. The patient presented with light expressive aphasic disorder and periods of unresponsiveness and could no longer perform executive functions. Figure 10 shows an MRI scan of a male patient with a biopsy proven diffuse astrocytoma grade 2. This patient presented with word retrieval disturbance for several months, headache and insecure while walking. The patient passed away 9 months after the MRI.
Description of symptoms in splenial involvement of GBM and gliomatosis cerebri has been limited to case reports.
Yapici-Eser et al. describe a 46-year-old women with a GBM, presenting with fatigue, and depressive symptoms, consisting of anhedonia (inability to experience pleasure) and avolition (decrease in motivation to perform self-directed purposeful activities). She also had psychomotor retardation and increased sleep. Neuropsychological testing revealed primary verbal and visual memory impairment [84].
Kiely and Twomey report a case of a 61-year-old male, with a histologically confirmed GBM involving the splenium on MRI, presenting with disorientation besides more general features of increased intracranial pressure [90].
B2b. Lymphoma and hypothesis for local development in the splenium
Primary central nervous system lymphoma (PCNSL) is a rare tumor, accounting for 2.8% of all primary brain tumors [91]. Its involvement of the CC has been reported in 14–28% [92, 93]. Splenial involvement in PCNSL has been described by Bruno et al. in 6/7 cases with TERTp-mutated PCNSL [94]. Although these and other reports only show images with splenial PCNSL, this involvement is not specifically mentioned in the text [82, 92, 93, 95]. The reason for this tendency is not understood, but may be related to microglia, T cell lymphocytes and perivascular spaces.
Approximately 90% of PCNSLs are diffuse large B cell non-Hodgkin lymphomas (DLBCLs), while primary T cell lymphomas constitute about 2% [93, 96–98]. DLBCLs are composed of immunoblasts with an angiocentric pattern. Focally prominent reactive astrocytic and microglial response is common, as well as reactive T cell lymphocytic infiltrates presence in varying degrees, with predominance of small CD4-positive T cells [93, 98].
Prinz et al. in 2014 conclude that the microglial cells derive from the multipotential hematopoietic stem cells, just like the lymphocytes involved in other forms of lymphoma [99]. Microglia cells play a role in brain development and maintenance of neuronal networks, but are also seen as the macrophages of the CNS. They differ from the “normal” macrophages elsewhere in the body, but have a similar function in eliminating microbes and dead cells [100]. High numbers of macrophages have been found in perivascular spaces. These macrophages interact with lymphocytes in the blood to promote local immune responses [101]. During inflammatory processes, activated T cells located within the perivascular spaces are able to cross the blood brain barrier and bind to microglia. These spaces therefore play an important role in lymphocyte trafficking [102] and are also referred to as the glymphatic system [101].
The greater number of perivascular spaces in the splenium may be associated with a larger number of neighboring microglia cells. In 1939, Kershman referred to del Río Hortega, who first described nests of microglia, which have also been referred to as microglial ‘fountains’ from which microglia cells are constantly projected into the brain. In addition, there are smaller foci where ameboid perivascular cells and submeningeal ameboid elements develop into mature branched microglia cells [103]. Once activated by a trigger, microglia cells change from an immunological inert state into an amoeboid round form and display behavior similar to macrophages in the blood. Amoeboid microglia cells have been demonstrated in the CC [104].
PCNSL tumor spread along perivascular spaces has been suggested by Batchelor and Loeffler [93]. They point out that enhancement in PCNSL shows a characteristic pattern, emanating from the CC. We suggest that compared with the remainder of the CC, its splenial involvement may be explained by its thicker size with a greater number of perivascular spaces surrounding perforators, related to the pericallosal pial plexus [18, 19].
Imaging characteristics of PCNSL vary widely among cases. On MRI, due to hypercellularity, lymphomas are isointense with gray matter on T2 and iso- or hypointense on T1-weighted images, with significant diffusion restriction on DWI/ADC. Contrast enhancement is intense and homogenous in about 85–95% of cases, but can be inhomogeneous or even missing. Figure 11 shows a case of a male patient presenting with leftsided homonymous hemianopia, leftsided sensory disturbances and a 3rd nerve palsy on the left, with a large cell B cell lymphoma located in the splenium.
Clinical signs are generally rapidly progressive and non-specific. In about 50–70% personality changes and cognitive impairment are found [105], which could be related to the splenium.
B3. Inflammatory diseases
Many inflammatory diseases, such as MS, and neuromyelitis optica spectrum disorder and vasculitis may lead to lesions in the CC; however, they generally are not limited to the splenium and therefore are not included in this section.
B3a. Tumefactive acute encephalomyelitis
The splenium may be involved in inflammatory brain disease such as acute tumefactive demyelinating encephalomyelitis (ADEM) through local extension from a location in the adjacent parietal lobe white matter. The inflammation may be triggered by a viral infection or vaccination. On MRI, gray and white matter may be involved with focal areas of high T2 signal, with variable enhancement [106]. The splenium may be affected together with lesions elsewhere in the brain and spine. Figure 12 shows a case of an older male patient, presenting with a cerebellar syndrome, sensory disturbance and weakness in the right leg, dysarthria, eyemovement disorder and alternating confusion with delireum, followed by depression. Biopsy of the splenial lesion showed demyelination with T cell infiltrate and slight secondary axonal injury, consistent with ADEM.
B3b. Susac's syndrome
Susac syndrome is an autoimmune endotheliopathy, known to affect the CC in females, between the ages 20–40, presenting with the classic triad of hearing loss, retinal artery occlusion and encephalopathy based on microangiopathy [107]. Although MRI shows typical “snowball lesions” representing microinfarcts throughout the entire CC [107], in multiple case reports, these lesions are shown to be present in the splenium, suggesting a preference for this area [108, 109].
Symptoms include headache, and during the encephalopathy phase early manifestations include acute altered mental status, personality changes, including depression, and are followed by memory loss and dementia [108].
C. Congenital and acquired pathology involving the splenium in a general disorder
C1. Developmental disorders
C1a. Agenesis and dysgenesis
Agenesis of the corpus callosum (ACC) is one of the most common brain developmental disorders. Incidence of ACC varies among 0.5–70 in every 10,000 births [110]. In children with mental retardation, its prevalence is estimated to be up to 230 ACCs in 10,000 births. The exact prevalence of isolated splenial agenesis, however, is unknown [111]. A multitude of genetic mutations is known to affect the development of the splenium, leading to dysgenesis or agenesis. Hanna et al. provide a schematic overview of different appearances of CC dysgenesis and agenesis [112]. MRI scans of three patients with different genetic mutations associated with dysgenesis are presented in Fig. 13.
Often, splenial dysgenesis or agenesis is found in the presence of other structural anomalies in the CNS, such as microcephaly, Dandy-Walker syndrome or polymicrogyria, heterotopia and cortical dysplasia. In holoprosencephaly, an atypical CC dysgenesis has been described, with formation of the posterior part of the CC, including the splenium, and absence of the anterior portion [113].
Contradictory findings have been published on agenesis of the entire CC and development. A meta-analysis of nine studies suggests that 70% of children, prenatally diagnosed with isolated CC agenesis, develops normally [114]. However, there are also several studies which report the opposite [110, 115]. Whether clinical features are related to the absence of the splenium, or to the associated bilateral hippocampal malrotation is unknown.
A review study by Chiarello has compared behavioral strategies and performance of spatial and linguistic functions in patients with ACC and split brain patients. She describes that callosal agenesis is often accompanied by spatiomotor function impairment. On the contrary, commisurectomy cases are unable to perform tasks requiring integration or intrahemispheric transfer of information, such as verbal response to leftsided visual input [116], presumably due to splenial involvement.
C1b. Lipoma
Intracranial lipomas are rare congenital malformations, which are believed to result from abnormal persistence and maldifferentiation of the primitive meninges during development of the subarachnoid cisterns [117]. Others report that they account for 0.46–1% of intracranial tumors [118]. Intracranial lipomas mainly occur at or near the midline, in the region of the pericallosal cistern and the CC, with curvilinear lipomas sweeping around a dysplastic splenial segment [1]. Agenesis or dysgenesis of the CC is the most frequently associated brain anomaly [119].
On T1-weighted MR images, they are very hyperintense, as shown in Fig. 14a, which shows the scan of a child with a SOX 2 gene mutation and developmental delay, particularly affecting speech and motor development. On CT, lipomas are extremely hypodense with a very low Hounsfield unit value. This is shown in Fig. 14b demonstrating a CT scan made of an older patient scanned for neurological deficit related to a cerebrovascular attack, with a coincidental finding of a lipoma curving along a normal splenium.
Most intracranial lipomas are asymptomatic and considered an incidental finding on imaging.
C1c. Infarction and hypoxic ischemic encephalopathy
Infarctions restricted to the CC are rare, because of its rich blood supply from the different arteries bilaterally. Furthermore, the perpendicular orientation of the callosal branches may prevent embolization [120]. If infarction is restricted to the CC, it is mostly found in the splenium [19, 120]. Splenial infarction may be considered a watershed area, because of the anastomosis between the endbranches of the anterior and posterior communicating arteries. Isolated occlusion of these arteries does not necessarily lead to interruption of blood supply to the splenium with subsequent infarction [120]. In Fig. 15a, b, a DWI/ADC map shows an area of cytotoxic edema, compatible with acute ischemia in the right side of the splenium, in a female patient presenting with acute dysarthria, without cognitive disturbance. The scan shows older lacunar infarcts in the corona radiata and left frontal white matter during the acute phase (Fig. 15c, d). On follow-up, a small residual lacune is seen in the area of cytoxic edema seen during the acute phase, in addition to a lacune in the left thalamus (Fig. 15e). No abnormalities were seen on the MRA (Fig. 15f).
In neonates with hypoxic ischemic encephalopathy (HIE), parietal-occipital infarction may lead to a secondary involvement of the splenium with diffusion restriction on DWI, compatible with cytotoxic edema. FA decrease may be found, suggesting loss of myelinated axonal integrity [121, 122].
Alderliesten et al. described an adverse neurological outcome in term neonates with diffusion restriction in the posterior CC [123]. However, most children also have abnormalities elsewhere and it is difficult to know which clinical signs could be attributed to the splenial involvement alone.
C1d. Traumatic lesions
During trauma, the CC is restricted in left to right movement because of its narrow relationship with the posterior falx. The splenium has an additional movement restriction in caudo-cranial direction because of the tentorium below. This leads to an increased susceptibility to traumatic injury [124, 125]. After high energy trauma, it is considered part of diffuse axonal injury [126, 127]. In the acute phase, diffusion restriction may been seen on DWI, as shown in Fig. 16, made of a child after high energy trauma with GCS score 1-2-1. Microhemorrhages may be seen on susceptibility weighted imaging (not shown). At follow up these lesions often show focal tissue loss with CSF signal due to disruption of crossing fibers. Figure 17a illustrates a large acute hyperdense subdural hematoma with brain swelling and clear midline shift on a CT scan, made following trauma in an older male patient, presenting initially with paralysis of the right arm and aphasia, with subsequent hemianopia and disorientation post craniectomy. The midline shift could potentially compress the splenial artery against the tentorium, leading to focal infarction as is shown on the postcraniectomy CT in figure 17b and follow up MRI scan in figure 17c-d (see section on Vascularization and Infarction) [124].
Clinically, acute severing of the crossing fibers following head trauma is highly associated with poor functional outcome [126, 127] and often leads to hampering of regaining consciousness (see paragraph Function).
C1e. Splenium in intracranial hypotension syndrome
Intracranial hypotension is thought to result from CSF hypovolemia due to a spinal CSF leak. To compensate, several mechanisms come into play and can be seen on MRI: downward displacement of the brain with sagging brainstem, pituitary volume increase, dilatation of veins and dural sinuses, thickening and enhancement of the dura and sometimes subdural hematomas [128, 129]. Another sign which has been described is a particular shape and position of the splenium, which appears stumpy and displaced downwards [129]. This is well demonstrated in Fig. 17 showing an MRI scan made of a male patient, presenting with headache in upright position, which decreased with reclining. Clinically, position-dependent headache, worsening with upright position is referred to as orthostatic headache. Atypical presentations reported in literature include short-term memory problems and a not-otherwise specified subcortical type of cognitive impairment, obtundation, stupor, drowsiness and even coma [130]. Although the compressions of the midbrain tegmentum and brainstem impression have been implicated in some of the clinical signs [128], we suggest that disturbed consciousness and memory could be attributed to splenial swelling and/or herniation (Figure 18).
Conclusion
We have presented an overview of development and function of the splenium and of pathology primarily affecting the splenium, extending into or from the splenium and involving the splenium in a general disorder. We have suggested hypotheses for the predilection of certain diseases and disorders for the splenium and for the associated clinical presentation. In acquired pathological processes, the splenium appears to play a role in consciousness.
Abbreviation
- AC
anterior commissure
- ACC
agenesis of the corpus callosum
- ADEM
acute disseminated encephalomyelitis
- ADH
anti-diuretic hormone
- AED
anti-epileptic drugs
- AVP
arginine-vasopressin
- CC
corpus callosum
- CLOCC
cytotoxic lesions of the corpus callosum
- DLBCL
diffuse large B cell lymphoma
- GBM
glioblastoma multiforme
- HC
hippocampal commissure
- HIE
hypoxic ischemic encephalopathy
- MERS
mild encephalitis/encephalopathy with a reversible splenial lesion
- PCNSL
primary central nervous system lymphoma
- RESLES
reversible splenial lesions syndrome
Funding Information
No funding was received for this study.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This is a review study for which no ethical approval of a research committee was required.
Informed consent
This is a review study for which no informed consent was required.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Raybaud C. The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation. Neuroradiology. 2010;52:447–477. doi: 10.1007/s00234-010-0696-3. [DOI] [PubMed] [Google Scholar]
- 2.Takanashi J, Tada H, Kuroki H, Barkovich AJ. Delirious behavior in influenza is associated with a reversible splenial lesion. Brain Dev. 2009;31:423–426. doi: 10.1016/j.braindev.2008.07.013. [DOI] [PubMed] [Google Scholar]
- 3.Barkovich AJ, Norman D. Anomalies of the corpus callosum: correlation with further anomalies of the brain. Am J Roentgenol. 1988;151:171–179. doi: 10.2214/ajr.151.1.171. [DOI] [PubMed] [Google Scholar]
- 4.Rakic P, Yakovlev PI. Development of the corpus callosum and cavum septi in man. J Comp Neurol. 1968;132:45–72. doi: 10.1002/cne.901320103. [DOI] [PubMed] [Google Scholar]
- 5.Kier EL, Fulbright RK, Bronen RA. Limbic lobe embryology and anatomy: dissection and MR of the medial surface of the fetal cerebral hemisphere. AJNR Am J Neuroradiol. 1995;16:1847–1853. [PMC free article] [PubMed] [Google Scholar]
- 6.Hannay HJ, Dennis M, Kramer L, Blaser S, Fletcher JM. Partial agenesis of the corpus callosum in spina bifida meningomyelocele and potential compensatory mechanisms. J Clin Exp Neuropsychol. 2009;31:180–194. doi: 10.1080/13803390802209954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hofer S, Frahm J. Topography of the human corpus callosum revisited—comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage. 2006;32:989–994. doi: 10.1016/j.neuroimage.2006.05.044. [DOI] [PubMed] [Google Scholar]
- 8.Ranson SW, Clark SI. The anatomy of the nervous system. 10. Philadelphia and London: W.B Saunders Company; 1959. pp. 334–338. [Google Scholar]
- 9.Sato N, Hatakeyama S, Shimizu N, Hikima A, Aoki J, Endo K. MR evaluation of the hippocampus in patients with congenital malformations of the brain. AJNR Am J Neuroradiol. 2001;22:389–393. [PMC free article] [PubMed] [Google Scholar]
- 10.Knyazeva MG (2013) Splenium of corpus callosum: patterns of interhemispheric interaction in children and adults. Neural Plast 2013 [DOI] [PMC free article] [PubMed]
- 11.De Lacoste MC, Kirkpatrick JB, Ross ED. Topography of the human corpus callosum. J Neuropathol Exp Neurol. 1985;44:578–591. doi: 10.1097/00005072-198511000-00004. [DOI] [PubMed] [Google Scholar]
- 12.Aboitiz F, Scheibel AB, Fisher RS, Zaidel E. Fiber composition of the human corpus callosum. Brain Res. 1992;598:143–153. doi: 10.1016/0006-8993(92)90178-c. [DOI] [PubMed] [Google Scholar]
- 13.Thompson PM, Giedd JN, Woods RP, MacDonald D, Evans AC, Toga AW. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature. 2000;404:190. doi: 10.1038/35004593. [DOI] [PubMed] [Google Scholar]
- 14.Muetzel RL, Collins PF, Mueller BA, Schissel AM, Lim KO, Luciana M. The development of corpus callosum microstructure and associations with bimanual task performance in healthy adolescents. Neuroimage. 2008;39:1918–1925. doi: 10.1016/j.neuroimage.2007.10.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mathews MS, Linskey ME, Binder DK (2008) William P. van Wagenen and the first corpus callosotomies for epilepsy [DOI] [PubMed]
- 16.Swanson MR, Wolff JJ, Elison JT, Gu H, Hazlett HC, Botteron K, Styner M, Paterson S, Gerig G, Constantino J. Splenium development and early spoken language in human infants. Dev Sci. 2017;20:e12360. doi: 10.1111/desc.12360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Fabri M, Polonara G. Functional topography of human corpus callosum: an FMRI mapping study. Neural Plast. 2013;2013:251308. doi: 10.1155/2013/251308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kahilogullari G, Comert A, Ozdemir M, Brohi R, Ozgural O, Esmer A, Egemen N, Karahan S. Arterial vascularization patterns of the splenium: an anatomical study. Clin Anat. 2013;26:675–681. doi: 10.1002/ca.22114. [DOI] [PubMed] [Google Scholar]
- 19.Chrysikopoulos H, Andreou J, Roussakis A, Pappas J. Infarction of the corpus callosum: computed tomography and magnetic resonance imaging. Eur J Radiol. 1997;25:2–8. doi: 10.1016/s0720-048x(96)01155-2. [DOI] [PubMed] [Google Scholar]
- 20.Wolfram-Gabel R, Maillot C, Koritke JG. Arterial vascularization of the corpus callosum in man. Arch Anat Histol Embryol. 1989;72:43–55. [PubMed] [Google Scholar]
- 21.Wolfram-Gabel R, Maillot C. The venous vascularization of the corpus callosum in man. Surg Radiol Anat. 1992;14:17–21. doi: 10.1007/BF01628038. [DOI] [PubMed] [Google Scholar]
- 22.Paul LK. Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement. J Neurodev Disord. 2011;3:3. doi: 10.1007/s11689-010-9059-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Graham D, Tisdall MM, Gill D. Corpus callosotomy outcomes in pediatric patients: a systematic review. Epilepsia. 2016;57:1053–1068. doi: 10.1111/epi.13408. [DOI] [PubMed] [Google Scholar]
- 24.Jea A, Vachhrajani S, Widjaja E, Nilsson D, Raybaud C, Shroff M, Rutka JT. Corpus callosotomy in children and the disconnection syndromes: a review. Childs Nerv Syst. 2008;24:685–692. doi: 10.1007/s00381-008-0626-4. [DOI] [PubMed] [Google Scholar]
- 25.Fabri M, Pierpaoli C, Barbaresi P, Polonara G. Functional topography of the corpus callosum investigated by DTI and fMRI. World J Radiol. 2014;6:895–906. doi: 10.4329/wjr.v6.i12.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol. 2005;62:433–437. doi: 10.1001/archneur.62.3.433. [DOI] [PubMed] [Google Scholar]
- 27.Gloor P, Salanova V, Olivier A, Quesney L. The human dorsal hippocampal commissure: an anatomically identifiable and functional pathway. Brain. 1993;116:1249–1273. doi: 10.1093/brain/116.5.1249. [DOI] [PubMed] [Google Scholar]
- 28.Zhang J, Wei R, Peng G, Zhou J, Wu M, He F, Pan G, Gao J, Luo B (2017) Correlations between diffusion tensor imaging and levels of consciousness in patients with traumatic brain injury: a systematic review and meta-analysis. Sci Rep 7 [DOI] [PMC free article] [PubMed]
- 29.Bianchi MT, Sims JR. Restricted diffusion in the splenium of the corpus callosum after cardiac arrest. Open Neuroimaging J. 2008;2:1–4. doi: 10.2174/1874440000802010001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kampfl A, Schmutzhard E, Franz G, Pfausler B, Haring H, Ulmer H, Felber S, Golaszewski S, Aichner F. Prediction of recovery from post-traumatic vegetative state with cerebral magnetic-resonance imaging. Lancet. 1998;351:1763–1767. doi: 10.1016/S0140-6736(97)10301-4. [DOI] [PubMed] [Google Scholar]
- 31.Ho M, Moonis G, Ginat DT, Eisenberg RL. Lesions of the corpus callosum. Am J Roentgenol. 2013;200:W1–W16. doi: 10.2214/AJR.11.8080. [DOI] [PubMed] [Google Scholar]
- 32.Kontzialis M, Soares BP, Huisman TA. Lesions in the Splenium of the Corpus callosum on MRI in children: a review. J Neuroimaging. 2017;27:549–561. doi: 10.1111/jon.12455. [DOI] [PubMed] [Google Scholar]
- 33.Kazi AZ, Joshi PC, Kelkar AB, Mahajan MS, Ghawate AS. MRI evaluation of pathologies affecting the corpus callosum: a pictorial essay. Indian J Radiol Imaging. 2013;23:321–332. doi: 10.4103/0971-3026.125604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Garcia-Monco JC, Cortina IE, Ferreira E, Martínez A, Ruiz L, Cabrera A, Beldarrain MG. Reversible splenial lesion syndrome (RESLES): what's in a name? J Neuroimaging. 2011;21:e1–e14. doi: 10.1111/j.1552-6569.2008.00279.x. [DOI] [PubMed] [Google Scholar]
- 35.Hammami N, Drissi C, Sebai R, Araar M, Maatallah Y, Belghith L, Nagi S, Hentati F, Hamouda MB. Reversible metronidazole-induced encephalopathy. J Neuroradiol. 2007;34:133–136. doi: 10.1016/j.neurad.2007.01.127. [DOI] [PubMed] [Google Scholar]
- 36.Acharya G, Cruz Carreras MT, Rice TW (2017) 5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer. BMJ Case Rep. 10.1136/bcr-2017-222030 [DOI] [PMC free article] [PubMed]
- 37.Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. Am J Roentgenol. 2009;192:501–508. doi: 10.2214/AJR.07.3959. [DOI] [PubMed] [Google Scholar]
- 38.Loh Y, Watson WD, Verma A, Krapiva P. Restricted diffusion of the splenium in acute Wernicke's encephalopathy. J Neuroimaging. 2005;15:373–375. doi: 10.1177/1051228405279037. [DOI] [PubMed] [Google Scholar]
- 39.Wada A, Yoshida R, Oda K, Fukuba E, Uchida N, Kitagaki H. Acute encephalopathy associated with intravenous immunoglobulin therapy. AJNR Am J Neuroradiol. 2005;26:2311–2315. [PMC free article] [PubMed] [Google Scholar]
- 40.Takanashi J. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev. 2009;31:521–528. doi: 10.1016/j.braindev.2009.02.012. [DOI] [PubMed] [Google Scholar]
- 41.Malhotra HS, Garg RK, Vidhate MR, Sharma PK. Boomerang sign: clinical significance of transient lesion in splenium of corpus callosum. Ann Indian Acad Neurol. 2012;15:151–157. doi: 10.4103/0972-2327.95005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics. 2017;37:562–576. doi: 10.1148/rg.2017160085. [DOI] [PubMed] [Google Scholar]
- 43.Maeda M, Tsukahara H, Terada H, Nakaji S, Nakamura H, Oba H, Igarashi O, Arasaki K, Machida T, Takeda K. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions: report of eight additional cases and literature review. J Neuroradiol. 2006;33:229–236. doi: 10.1016/s0150-9861(06)77268-6. [DOI] [PubMed] [Google Scholar]
- 44.Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, Suzuki M, Yamamoto T, Shimono T, Ichiyama T, Taoka T, Sohma O, Yoshikawa H, Kohno Y. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004;63:1854–1858. doi: 10.1212/01.wnl.0000144274.12174.cb. [DOI] [PubMed] [Google Scholar]
- 45.da Rocha AJ, Reis F, Gama HPP, da Silva CJ, Braga FT, Maia ACM, Jr, Cendes F. Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients. Neuroradiology. 2006;48:731. doi: 10.1007/s00234-006-0116-x. [DOI] [PubMed] [Google Scholar]
- 46.Vanderschueren G, Schotsmans K, Marechal E, Crols R. Mild encephalitis with reversible splenial (MERS) lesion syndrome due to influenza B virus. Pract Neurol. 2018;18:391–392. doi: 10.1136/practneurol-2018-001880. [DOI] [PubMed] [Google Scholar]
- 47.Kaplan TB, Berkowitz AL. Reversible splenial lesion syndrome. Pract Neurol. 2016;16:78–79. doi: 10.1136/practneurol-2015-001195. [DOI] [PubMed] [Google Scholar]
- 48.Li G, Li S, Qi F, Mei G. Mild encephalitis/encephalopathy in children with a reversible splenial lesion. Radiol Infect Dis. 2018;5:118–122. [Google Scholar]
- 49.Nyhan WL, Cooke RE. Symptomatic hyponatremia in acute infections of the central nervous system. Pediatrics. 1956;18:604–613. [PubMed] [Google Scholar]
- 50.Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. J Am Geriatr Soc. 2006;54:345–353. doi: 10.1111/j.1532-5415.2005.00609.x. [DOI] [PubMed] [Google Scholar]
- 51.Giuliani C, Peri A. Effects of hyponatremia on the brain. J Clin Med. 2014;3:1163–1177. doi: 10.3390/jcm3041163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126:S1–S42. doi: 10.1016/j.amjmed.2013.07.006. [DOI] [PubMed] [Google Scholar]
- 53.Pohl HR, Wheeler JS, Murray HE (2013) Sodium and potassium in health and disease. In: Interrelations between essential metal ions and human diseases. Springer:29–47 [DOI] [PubMed]
- 54.Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3):iii22–iii28. doi: 10.1136/jnnp.2004.045906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Takanashi J, Shiihara T, Hasegawa T, Takayanagi M, Hara M, Okumura A, Mizuguchi M. Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination. J Neurol Sci. 2015;349:226–228. doi: 10.1016/j.jns.2014.12.019. [DOI] [PubMed] [Google Scholar]
- 56.Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia. 2005;46:1633–1636. doi: 10.1111/j.1528-1167.2005.00256.x. [DOI] [PubMed] [Google Scholar]
- 57.Gallucci M, Limbucci N, Paonessa A, Caranci F. Reversible focal splenial lesions. Neuroradiology. 2007;49:541–544. doi: 10.1007/s00234-007-0235-z. [DOI] [PubMed] [Google Scholar]
- 58.Anneken K, Evers S, Mohammadi S, Schwindt W, Deppe M. Transient lesion in the splenium related to antiepileptic drug: case report and new pathophysiological insights. Seizure. 2008;17:654–657. doi: 10.1016/j.seizure.2008.01.004. [DOI] [PubMed] [Google Scholar]
- 59.Takanashi J, Tada H, Maeda M, Suzuki M, Terada H, Barkovich AJ. Encephalopathy with a reversible splenial lesion is associated with hyponatremia. Brain Dev. 2009;31:217–220. doi: 10.1016/j.braindev.2008.04.002. [DOI] [PubMed] [Google Scholar]
- 60.Tsuji M, Yoshida T, Miyakoshi C, Haruta T. Is a reversible splenial lesion a sign of encephalopathy? Pediatr Neurol. 2009;41:143–145. doi: 10.1016/j.pediatrneurol.2009.02.019. [DOI] [PubMed] [Google Scholar]
- 61.Fong CY, Khine MMK, Peter AB, Lim WK, Rozalli FI, Rahmat K. Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) due to dengue virus. J Clin Neurosci. 2017;36:73–75. doi: 10.1016/j.jocn.2016.10.050. [DOI] [PubMed] [Google Scholar]
- 62.Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatr. 2001;70:459–463. doi: 10.1136/jnnp.70.4.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Dong X, Bai C, Nao J. Clinical and radiological features of Marchiafava-Bignami disease. Medicine (Baltimore) 2018;97:e9626. doi: 10.1097/MD.0000000000009626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Lin Y, Ho C, Chiu N, Tseng H, Hsu C, Huang J. The reversible corpus callosum splenium lesion in a neonate with hypoglycemia and seizure. Acta Neurol Taiwanica. 2015;24:15–18. [PubMed] [Google Scholar]
- 65.Katoh M, Yoshino M, Aoki T, Abumiya T, Imamura H, Aida T. Localized reversible high signal intensities on diffusion-weighted MRI in hypoglycemia: a study of 70 cases. Asian J Neurosurg. 2016;11:412. doi: 10.4103/1793-5482.144196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Wang C, Zong M, Lu S, Tian Z. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes. J Diabetes Complicat. 2016;30:1532–1536. doi: 10.1016/j.jdiacomp.2016.07.030. [DOI] [PubMed] [Google Scholar]
- 67.Kim SS, Chang KH, Kim ST, Suh DC, Cheon JE, Jeong SW, Han MH, Lee SK. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol. 1999;20:125–129. [PubMed] [Google Scholar]
- 68.Kim JH, Choi JY, Koh S, Lee Y. Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology. 2007;49:217–222. doi: 10.1007/s00234-006-0184-y. [DOI] [PubMed] [Google Scholar]
- 69.Conti M, Salis A, Urigo C, Canalis L, Frau S, Canalis G. Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Radiol Med. 2007;112:921–935. doi: 10.1007/s11547-007-0197-9. [DOI] [PubMed] [Google Scholar]
- 70.Pekala JS, Mamourian AC, Wishart HA, Hickey WF, Raque JD. Focal lesion in the splenium of the corpus callosum on FLAIR MR images: a common finding with aging and after brain radiation therapy. AJNR Am J Neuroradiol. 2003;24:855–861. [PMC free article] [PubMed] [Google Scholar]
- 71.Topcu M, Saatci I, Apak RA, Soylemezoglu F, Akcoren Z. Leigh syndrome in a 3-year-old boy with unusual brain MR imaging and pathologic findings. AJNR Am J Neuroradiol. 2000;21:224–227. [PMC free article] [PubMed] [Google Scholar]
- 72.Quinonez SC, Leber SM, Martin DM, Thoene JG, Bedoyan JK. Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency. Pediatr Neurol. 2013;48:67–72. doi: 10.1016/j.pediatrneurol.2012.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Zhou Z, Wu Y, Cao J, Hu J, Han Y, Hong M, Wang G, Liu S, Wang X. Characteristics of neurological Wilson’s disease with corpus callosum abnormalities. BMC Neurol. 2019;19:85. doi: 10.1186/s12883-019-1313-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Trocello JM, Guichard JP, Leyendecker A, Pernon M, Chaine P, El Balkhi S, Poupon J, Chappuis P, Woimant F. Corpus callosum abnormalities in Wilson's disease. J Neurol Neurosurg Psychiatr. 2011;82:1119–1121. doi: 10.1136/jnnp.2009.204651. [DOI] [PubMed] [Google Scholar]
- 75.Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy–neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016;12:606. doi: 10.1038/nrendo.2016.90. [DOI] [PubMed] [Google Scholar]
- 76.Berger J, Gärtner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta. 2006;1763:1721–1732. doi: 10.1016/j.bbamcr.2006.07.010. [DOI] [PubMed] [Google Scholar]
- 77.Engelen M, Kemp S, De Visser M, van Geel BM, Wanders RJ, Aubourg P. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012;7:51. doi: 10.1186/1750-1172-7-51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Poretti A, Meoded A, Bunge M, Fatemi A, Barrette P, Huisman TA, Salman MS. Novel diffusion tensor imaging findings in Krabbe disease. Eur J Paediatr Neurol. 2014;18:150–156. doi: 10.1016/j.ejpn.2013.09.008. [DOI] [PubMed] [Google Scholar]
- 79.Sakai N. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment. Brain Dev. 2009;31:485–487. doi: 10.1016/j.braindev.2009.03.001. [DOI] [PubMed] [Google Scholar]
- 80.Farina L, Bizzi A, Finocchiaro G, Pareyson D, Sghirlanzoni A, Bertagnolio B, Naidu S, Singhal BS, Wenger DA. MR imaging and proton MR spectroscopy in adult Krabbe disease. Am J Neuroradiol. 2000;21:1478–1482. [PMC free article] [PubMed] [Google Scholar]
- 81.Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol. 2003;18:595–603. doi: 10.1177/08830738030180090201. [DOI] [PubMed] [Google Scholar]
- 82.Park SE, Choi DS, Shin HS, Baek HJ, Choi HC, Kim JE, Choi HY, Park MJ. Splenial lesions of the corpus callosum: disease spectrum and MRI findings. Korean J Radiol. 2017;18:710–721. doi: 10.3348/kjr.2017.18.4.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, Slone HW, Kehagias D. Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. Am J Roentgenol. 2002;179:251–257. doi: 10.2214/ajr.179.1.1790251. [DOI] [PubMed] [Google Scholar]
- 84.Yapıcı-Eser H, Onay A, Öztop-Çakmak Ö, Egemen E, Vanlı-Yavuz EN, Solaroğlu İ (2016) Rare case of glioblastoma multiforme located in posterior corpus callosum presenting with depressive symptoms and visual memory deficits. BMJ Case Rep:2016 [DOI] [PMC free article] [PubMed]
- 85.Witoonpanich P, Bamrungrak K, Jinawath A, Wongwaisayawan S, Phudhichareonrat S, Witoonpanich R. Glioblastoma multiforme at the corpus callosum with spinal leptomeningeal metastasis. Clin Neurol Neurosurg. 2011;113:407–410. doi: 10.1016/j.clineuro.2010.12.001. [DOI] [PubMed] [Google Scholar]
- 86.Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. doi: 10.1007/s00401-007-0243-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–820. doi: 10.1007/s00401-016-1545-1. [DOI] [PubMed] [Google Scholar]
- 88.Peretti-Viton P, Brunel H, Chinot O, Daniel C, Barrié M, Bouvier C, Figarella-Branger D, Fuentes S, Dufour H, Grisoli F. Histological and MR correlations in Gliomatosis cerebri. J Neuro-Oncol. 2002;59:249–259. doi: 10.1023/a:1019934901750. [DOI] [PubMed] [Google Scholar]
- 89.Desclée P, Rommel D, Hernalsteen D, Godfraind C, de Coene B, Cosnard G. Gliomatosis cerebri, imaging findings of 12 cases. J Neuroradiol. 2010;37:148–158. doi: 10.1016/j.neurad.2009.12.001. [DOI] [PubMed] [Google Scholar]
- 90.Kiely F, Twomey F (2015) Butterfly Glioma involving Splenium of Corpus callosum. International journal of Clinical & Medical Images 2
- 91.Abrey LE. Primary central nervous system lymphoma. Curr Opin Neurol. 2009;22:675–680. doi: 10.1097/WCO.0b013e328332533b. [DOI] [PubMed] [Google Scholar]
- 92.Buhring U, Herrlinger U, Krings T, Thiex R, Weller M, Kuker W. MRI features of primary central nervous system lymphomas at presentation. Neurology. 2001;57:393–396. doi: 10.1212/wnl.57.3.393. [DOI] [PubMed] [Google Scholar]
- 93.Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol. 2006;24:1281–1288. doi: 10.1200/JCO.2005.04.8819. [DOI] [PubMed] [Google Scholar]
- 94.Bruno A, Alentorn A, Daniau M, Labussière M, Rahimian A, Tabouret E, Polivka M, Jouvet A, Adam C, Figarella-Branger D. TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium. Acta Neuropathol. 2015;130:439. doi: 10.1007/s00401-015-1461-9. [DOI] [PubMed] [Google Scholar]
- 95.Plasswilm L, Herrlinger U, Korfel A, Weller M, Küker W, Kanz L, Thiel E, Bamberg M. Primary central nervous system (CNS) lymphoma in immunocompetent patients. Ann Hematol. 2002;81:415–423. doi: 10.1007/s00277-002-0498-8. [DOI] [PubMed] [Google Scholar]
- 96.Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer. 1974;34:1488–1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- 97.Jellinger K, Radaskiewicz T, Slowik F (1975) Primary malignant lymphomas of the central nervous system in man. In: Malignant Lymphomas of the Nervous System. Springer, pp 95–102 [DOI] [PubMed]
- 98.Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med. 2008;132:1830–1834. doi: 10.5858/132.11.1830. [DOI] [PubMed] [Google Scholar]
- 99.Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014;15:300–312. doi: 10.1038/nrn3722. [DOI] [PubMed] [Google Scholar]
- 100.Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35 [DOI] [PMC free article] [PubMed]
- 101.Esiri M, Gay D. Immunological and neuropathological significance of the Virchow-Robin space. J Neurol Sci. 1990;100:3–8. doi: 10.1016/0022-510x(90)90004-7. [DOI] [PubMed] [Google Scholar]
- 102.Wuerfel J, Haertle M, Waiczies H, Tysiak E, Bechmann I, Wernecke KD, Zipp F, Paul F. Perivascular spaces—MRI marker of inflammatory activity in the brain? Brain. 2008;131:2332–2340. doi: 10.1093/brain/awn171. [DOI] [PubMed] [Google Scholar]
- 103.Kershman J. Genesis of microglia in the human brain. Arch Neurol Psychiatr. 1939;41:24–50. [Google Scholar]
- 104.Monier A, Evrard P, Gressens P, Verney C. Distribution and differentiation of microglia in the human encephalon during the first two trimesters of gestation. J Comp Neurol. 2006;499:565–582. doi: 10.1002/cne.21123. [DOI] [PubMed] [Google Scholar]
- 105.von Baumgarten L, Illerhaus G, Korfel A, Schlegel U, Deckert M, Dreyling M. The diagnosis and treatment of primary CNS lymphoma. Dtsch Arztebl Int. 2018;115:419–426. doi: 10.3238/arztebl.2018.0419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Tan H, Chan L, Chuah K, Goh N, Tang K. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol. 2004;77:153–156. doi: 10.1259/bjr/26682607. [DOI] [PubMed] [Google Scholar]
- 107.Rennebohm R, Susac JO, Egan RA, Daroff RB. Susac's syndrome—update. J Neurol Sci. 2010;299:86–91. doi: 10.1016/j.jns.2010.08.032. [DOI] [PubMed] [Google Scholar]
- 108.Hahn JS, Lannin WC, Sarwal MM. Microangiopathy of brain, retina, and inner ear (Susac's syndrome) in an adolescent female presenting as acute disseminated encephalomyelitis. Pediatrics. 2004;114:276–281. doi: 10.1542/peds.114.1.276. [DOI] [PubMed] [Google Scholar]
- 109.Xu MS, Tan CB, Umapathi T, Lim CT. Susac syndrome: serial diffusion-weighted MR imaging. Magn Reson Imaging. 2004;22:1295–1298. doi: 10.1016/j.mri.2004.08.006. [DOI] [PubMed] [Google Scholar]
- 110.Szabó N, Gergev G, Kóbor J, Bereg E, Túri S, Sztriha L. Corpus callosum anomalies: birth prevalence and clinical spectrum in Hungary. Pediatr Neurol. 2011;44:420–426. doi: 10.1016/j.pediatrneurol.2011.01.002. [DOI] [PubMed] [Google Scholar]
- 111.Schell-Apacik CC, Wagner K, Bihler M, Ertl-Wagner B, Heinrich U, Klopocki E, Kalscheuer VM, Muenke M, von Voss H. Agenesis and dysgenesis of the corpus callosum: clinical, genetic and neuroimaging findings in a series of 41 patients. Am J Med Genet A. 2008;146:2501–2511. doi: 10.1002/ajmg.a.32476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Hanna RM, Marsh SE, Swistun D, Al-Gazali L, Zaki MS, Abdel-Salam GM, Al-Tawari A, Bastaki L, Kayserili H, Rajab A, Boglarka B, Dietrich RB, Dobyns WB, Truwit CL, Sattar S, Chuang NA, Sherr EH, Gleeson JG. Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families. Neurology. 2011;76:373–382. doi: 10.1212/WNL.0b013e318208f492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Oba H, Barkovich AJ. Holoprosencephaly: an analysis of callosal formation and its relation to development of the interhemispheric fissure. AJNR Am J Neuroradiol. 1995;16:453–460. [PMC free article] [PubMed] [Google Scholar]
- 114.Mangione R, Fries N, Godard P, Capron C, Mirlesse V, Lacombe D, Duyme M. Neurodevelopmental outcome following prenatal diagnosis of an isolated anomaly of the corpus callosum. Ultrasound Obstet Gynecol. 2011;37:290–295. doi: 10.1002/uog.8882. [DOI] [PubMed] [Google Scholar]
- 115.Kim YU, Park ES, Jung S, Suh M, Choi HS, Rha D. Clinical features and associated abnormalities in children and adolescents with corpus callosal anomalies. Ann Rehabil Med. 2014;38:138. doi: 10.5535/arm.2014.38.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Chiarello C. A house divided? Cognitive functioning with callosal agenesis. Brain Lang. 1980;11:128–158. doi: 10.1016/0093-934x(80)90116-9. [DOI] [PubMed] [Google Scholar]
- 117.Truwit CL, Barkovich AJ. Pathogenesis of intracranial lipoma: an MR study in 42 patients. AJR Am J Roentgenol. 1990;155:855–864. doi: 10.2214/ajr.155.4.2119122. [DOI] [PubMed] [Google Scholar]
- 118.Yilmaz N, Unal O, Kiymaz N, Yilmaz C, Etlik O. Intracranial lipomas—a clinical study. Clin Neurol Neurosurg. 2006;108:363–368. doi: 10.1016/j.clineuro.2005.04.003. [DOI] [PubMed] [Google Scholar]
- 119.Yildiz H, Hakyemez B, Koroglu M, Yesildag A, Baykal B. Intracranial lipomas: importance of localization. Neuroradiology. 2006;48:1–7. doi: 10.1007/s00234-005-0001-z. [DOI] [PubMed] [Google Scholar]
- 120.Li S, Sun X, Bai Y, Qin H, Wu X, Zhang X, Jolkkonen J, Boltze J, Wang S. Infarction of the corpus callosum: a retrospective clinical investigation. PLoS One. 2015;10:e0120409. doi: 10.1371/journal.pone.0120409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Takenouchi T, Heier LA, Engel M, Perlman JM. Restricted diffusion in the corpus callosum in hypoxic-ischemic encephalopathy. Pediatr Neurol. 2010;43:190–196. doi: 10.1016/j.pediatrneurol.2010.04.014. [DOI] [PubMed] [Google Scholar]
- 122.Righini A, Doneda C, Parazzini C, Arrigoni F, Matta U, Triulzi F. Diffusion tensor imaging of early changes in corpus callosum after acute cerebral hemisphere lesions in newborns. Neuroradiology. 2010;52:1025–1035. doi: 10.1007/s00234-010-0745-y. [DOI] [PubMed] [Google Scholar]
- 123.Alderliesten T, de Vries LS, Khalil Y, van Haastert IC, Benders MJ, Koopman-Esseboom C, Groenendaal F. Therapeutic hypothermia modifies perinatal asphyxia-induced changes of the corpus callosum and outcome in neonates. PLoS One. 2015;10:e0123230. doi: 10.1371/journal.pone.0123230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Kuchta J, Wedekind C, Ernestus R, Klug N. The hour-glass model of corpus callosum injury. Cent Eur Neurosurg. 2009;70:125–129. doi: 10.1055/s-0029-1214384. [DOI] [PubMed] [Google Scholar]
- 125.Shiramizu H, Masuko A, Ishizaka H, Shibata M, Atsumi H, Imai M, Osada T, Mizokami Y, Baba T, Matsumae M. Mechanism of injury to the corpus callosum, with particular reference to the anatomical relationship between site of injury and adjacent brain structures. Neurol Med. 2008;48:1–7. doi: 10.2176/nmc.48.1. [DOI] [PubMed] [Google Scholar]
- 126.van Eijck MM, Schoonman GG, van der Naalt J, de Vries J, Roks G. Diffuse axonal injury after traumatic brain injury is a prognostic factor for functional outcome: a systematic review and meta-analysis. Brain Inj. 2018;32:395–402. doi: 10.1080/02699052.2018.1429018. [DOI] [PubMed] [Google Scholar]
- 127.Cicuendez M, Castaño-León A, Ramos A, Hilario A, Gómez PA, Lagares A. Prognostic value of corpus callosum injuries in severe head trauma. Acta Neurochir. 2017;159:25–32. doi: 10.1007/s00701-016-3000-4. [DOI] [PubMed] [Google Scholar]
- 128.Capizzano AA, Lai L, Kim J, Rizzo M, Gray L, Smoot MK, Moritani T. Atypical presentations of intracranial hypotension: comparison with classic spontaneous intracranial hypotension. AJNR Am J Neuroradiol. 2016;37:1256–1261. doi: 10.3174/ajnr.A4706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Savoiardo M, Minati L, Farina L, De Simone T, Aquino D, Mea E, Filippini G, Bussone G, Chiapparini L. Spontaneous intracranial hypotension with deep brain swelling. Brain. 2007;130:1884–1893. doi: 10.1093/brain/awm101. [DOI] [PubMed] [Google Scholar]
- 130.Whiteley W, Al-Shahi R, Myles L, Lueck C. Spontaneous intracranial hypotension causing confusion and coma: a headache for the neurologist and the neurosurgeon. Br J Neurosurg. 2003;17:456–458. doi: 10.1080/02688690310001611251. [DOI] [PubMed] [Google Scholar]